THOC1 and glioblastoma: Survival analysis of publicly available GBM datasets (GlioVis) revealed that higher THOC1 RNA expression strongly correlates with shorter patient survival, corroborating its role in promoting GBM aggressiveness and clinical relevance as a potential therapeutic target (p<0.05) (Fig. 2A).